Stevens-Johnson syndrome and toxic epidermal necrolysis: risk factors, causality assessment and potential prevention strategies.

Expert Review of Clinical Immunology
Chu-Chi LinWen-Hung Chung

Abstract

Introduction: The clinical manifestations of cutaneous adverse drug reactions are variable with different severity. Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening severe cutaneous adverse reactions (SCARs) majorly caused by drugs and mediated by cytotoxic T cells.Areas covered: In this review, we focus on risk factors that contribute to the development of SJS/TEN and review the updated immune mechanism, preventive strategies as well as current therapeutic approaches for SJS/TEN.Expert opinion: The progress of SJS/TEN researches reveals that cytotoxic T cells majorly activated by drug interacted with the human leukocyte antigen (HLA) and T cell receptors play an important role for the immune mechanism of SJS/TEN. Several clinical assessment tools and in vitro drug-T cells activation tests have been developed to identify the causality of SJS/TEN. New therapeutic approaches and biologics such as TNF-alpha antagonist have been conducted to improve the prognosis of SJS/TEN.

References

Aug 1, 1981·Clinical Pharmacology and Therapeutics·C A NaranjoD J Greenblatt
Nov 1, 1995·Archives of Dermatology·B CôtéJ C Roujeau
Apr 1, 1996·The British Journal of Dermatology·C PaulJ C Roujeau
Jun 1, 1997·European Journal of Immunology·E PadovanH U Weltzien
Feb 14, 1998·The Journal of Clinical Investigation·C Gutierrez-SteilB J Nickoloff
Aug 24, 1999·Immunology and Cell Biology·P Waring, A Müllbacher
Apr 20, 2001·Cytokine & Growth Factor Reviews·Y LeJ M Wang
Jan 19, 2002·The Journal of Allergy and Clinical Immunology·Sinforiano J PosadasMiguel Blanca
Apr 12, 2002·Lancet·Seth HetheringtonAllen D Roses
Jul 12, 2002·Nature·Paola ScaffidiMarco E Bianchi
Sep 25, 2002·Journal of the American Academy of Dermatology·Payam Tristani-FirouziJohn J Zone
Dec 11, 2002·The Journal of Biological Chemistry·Isabelle Viard-LeveugleLars E French
Apr 23, 2003·The American Journal of Pathology·Riichiro AbeHiroshi Shimizu
Nov 25, 2003·The British Journal of Dermatology·F Fiszenson-AlbalaV Descamps
Apr 2, 2004·Nature·Wen-Hung ChungYuan-Tsong Chen
Jul 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Patrick SchaerliWerner J Pichler
Feb 3, 2005·Cell Research·Zheng Gang Liu
Mar 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Shuen-Iu HungYuan-Tsong Chen
Aug 3, 2006·The British Journal of Dermatology·H PeyrièreUNKNOWN Network of the French Pharmacovigilance Centers
Dec 2, 2006·The Journal of Investigative Dermatology·Karoline SturGeorg Stingl
Jan 12, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Lina H K Lim, Shazib Pervaiz
Jul 10, 2007·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·H G KangX X Zheng
Jan 15, 2008·Pharmacogenetics and Genomics·Christine LonjouUNKNOWN RegiSCAR study group
Feb 8, 2008·The New England Journal of Medicine·Simon MallalUNKNOWN PREDICT-1 Study Team
Feb 28, 2008·Nature Reviews. Immunology·Vanessa VenturiMiles P Davenport
Dec 24, 2008·Pharmacogenetics and Genomics·Soranun ChantarangsuYusuke Nakamura
Apr 2, 2009·The Journal of Dermatology·Emanuela GubinelliBiagio Didona
Oct 7, 2009·Annals of Internal Medicine·Riichiro AbeHiroshi Shimizu
May 12, 2010·Clinical and Experimental Dermatology·R RajaratnamH Lewis
May 27, 2010·The British Journal of Dermatology·L Valeyrie-AllanoreJ C Roujeau
Sep 24, 2010·The Journal of Dermatology·Burkhard KreftWolfgang Christian Marsch
Feb 9, 2011·Pharmacogenetics and Genomics·Hye-Ryun KangUNKNOWN Adverse Drug Reaction Research Group in Korea

❮ Previous
Next ❯

Citations

Sep 30, 2020·Allergy·Adriana ArizaTahia D Fernandez
Sep 9, 2020·Journal of the European Academy of Dermatology and Venereology : JEADV·C-B ChenUNKNOWN Taiwan Severe Cutaneous Adverse Reaction Consortium

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.